The AYA Oncology Self-care Movement

Part of paid clinical trials in Chicago, Illinois.

Sponsor
Northwestern University
Study ID
NCT07724652
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Acute Lymphobkastic Leukemia
  • Medication Adherence

Eligibility Criteria

Sex
ALL
Age
15 Years - 25 Years
Healthy Volunteers
Not accepted

Interventions

  • Educational Website — BEHAVIORAL
    Website providing basic information about 6-mercaptopurine (e.g., type, what it is used for, strategies for remembering to take it)
  • #AYAOSM — BEHAVIORAL
    Social media messages (videos/images) that target medication self-management skills/knowledge, self-efficacy, and social support. Messages were created in collaboration with young adult cancer survivors who are also prominent content creators or "influencers".

Study Details

This trial will test the impact of a social media intervention for improving oral chemotherapy adherence among adolescents and young adults (AYAs) with acute lymphoblastic leukemia.

Key Dates

First listed
Jul 24, 2026
Start date
Nov 1, 2026
Status verified
Jul 2026
Primary completion
Aug 31, 2030
Completion
Aug 31, 2030

Study Design

Enrollment
200 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: #AYAOSM
    Across the 12-week intervention period, participants in this condition will receive \~2-3 distinct, tailored social media messages per week aimed at promoting 6-mercaptopurine (6-MP) adherence. Messages will be delivered using direct messaging to the participant's own social media account (e.g., TikTok or Instagram), from a study-created social media account. Messages will feature the influencers (i.e., their own images/videos) and/or be branded with their account handles to signify their involvement in creating the message. Participants will also receive access to an educational website.
  • Active Comparator: Educational Website Only
    Provides basic details about what 6-mercaptopurine is, what it is used for, and how to remember to take it.

Primary Outcome Measure

Electronically-monitored Medication Adherence [ Time Frame: 6-months ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Ann & Robert H. Lurie Children's Hospital of ChicagoChicagoIllinois60611
Alexandra Psihogios, Ph.D.
[email protected]
2409946546
Alexandra Psihogios, Ph.D. (PRINCIPAL_INVESTIGATOR)
Northwestern UniversityChicagoIllinois60611
Alexandra Psihogios, Ph.D.
[email protected]
240-994-6546
Alexandra Psihogos, PhD (SUB_INVESTIGATOR)
Betina Yanez, Ph.D. (PRINCIPAL_INVESTIGATOR)
The Children's Hospital of PhiladelphiaPhiladelphiaPennsylvania19104
Lisa Schwartz, PhD
[email protected]
267-426-0355
Lisa Schwartz, PhD (PRINCIPAL_INVESTIGATOR)
MD Anderson Cancer CenterHoustonTexas77030
Michael Roth, MD
[email protected]
1-877-632-6789
Michael Roth, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chicago, IL

By research site
Ann & Robert H. Lurie Children's Hospital of Chicago· Chicago, ILNorthwestern University· Chicago, ILThe Children's Hospital of Philadelphia· Philadelphia, PAMD Anderson Cancer Center· Houston, TX

Related Studies